1-20 of 43
Sarah C. Rutherford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress - Alliance A051901 - Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction Followed By Lenalidomide and Nivolumab Maintenance in Primary Central Nervous System Lymphoma (PCNSL)

Alvaro J Alencar, Olivia Bobek, Neha Mehta-Shah, Narendranath Epperla, Christine Lu-Emerson, Sarah C. Rutherford, Adam J. Olszewski, Thomas Ollila, Samuel Singer, Travis Dockter, Susan M. Geyer, Lori Rosenstein, Macarena De La Fuente, Eric D. Hsi, Shira N. Dinner, James L. Rubenstein, Nancy L. Bartlett, John P. Leonard
Journal: Blood
Blood (2024) 144 (Supplement 1): 4502.4.
https://doi.org/10.1182/blood-2024-209238
Published: 2024
Journal Articles

Enhancing Diagnostic and Prognostic Strategies in Secondary HLH: Insights from the Weill-Cornell Medicine Experience

Justin D. Kaner, Danny Luan, Franco Castillo Tokumori, John-William Sidhom, Jose Fernandez-Rengifo, Samantha Gerson, Matthew Whitcomb, Molly Vallon, Ellen K. Ritchie, Michael Samuel, Jonathan Canaani, Michal Bar-Natan, Erin Mulvey, Peter Martin, Pinkal Desai, John N. Allan, Richard R. Furman, Sarah C. Rutherford, Jia Ruan, Gail J. Roboz
Journal: Blood
Blood (2024) 144 (Supplement 1): 5379.
https://doi.org/10.1182/blood-2024-210134
Published: 2024
Journal Articles

MRD-Driven Time-Limited Therapy of Acalabrutinib and Lenalidomide Plus Rituximab (ALR) or Obinutuzumab (ALO) in Patients with Treatment-Naïve Mantle Cell Lymphoma: Phase 2 Trial Outcomes with MRD and cfDNA Analyses

Jia Ruan, David A. Bond, Bijal D Shah, John N. Allan, Sarah C. Rutherford, Caitlin Gribbin, Zhengming Chen, Brittany Hobbie, Melinda Harbhajan, Tejasvi Sahni, Wayne Tam, Bhavneet Bhinder, Michael Sigouros, Giorgio Inghirami, Selina Chen-Kiang, Olivier Elemento, Kami J. Maddocks, John P. Leonard, Peter Martin
Journal: Blood
Blood (2024) 144 (Supplement 1): 746.
https://doi.org/10.1182/blood-2024-204495
Published: 2024
Journal Articles

Disease Course and Risk Model Validation of Asymptomatic Waldenström Macroglobulinemia Patients - a Single Center Experience

Theresia Akhlaghi, Jose Fernandez-Rengifo, Mateo Mejia Saldarriaga, Sarah C. Rutherford, Cara Rosenbaum, Jorge Monge, Peter Martin, John N. Allan, Richard R. Furman, Ruben Niesvizky, Mark Bustoros
Journal: Blood
Blood (2024) 144 (Supplement 1): 6350.
https://doi.org/10.1182/blood-2024-210059
Published: 2024
Journal Articles

Subsequent Treatment and Clinical Outcome Following Induction Therapy on a Phase II Study of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL)

Jia Ruan, Evelyn H. Orlando, Alison Moskowitz, Zhengming Chen, Neha Mehta-Shah, Lubomir Sokol, Steven Horwitz, Sarah C. Rutherford, Tejasvi Sahni, Ari M Melnick, Giorgio Inghirami, Leandro Cerchietti, John P. Leonard, Peter Martin
Journal: Blood
Blood (2024) 144 (Supplement 1): 1693.
https://doi.org/10.1182/blood-2024-206606
Published: 2024
Journal Articles

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Clinical Trials & Observations
David A. Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham T. Wehmeyer, Jason Romancik, Behzad Amoozgar, Lori Leslie, Loretta J. Nastoupil, Jennifer L. Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami Maddocks, Sarah C. Rutherford, Brad Kahl, Michelle Okwali, Michael J. Buege, Venkatraman Seshan, Connie L. Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (26): 2327–2331.
https://doi.org/10.1182/blood.2023021274
Published: 2023
Includes: Supplemental data
Journal Articles

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Sharon M. Castellino, Hongli Li, Alex F. Herrera, Angela Punnett, Michael Leblanc, Susan K Parsons, David Hodgson, Frank Keller, Richard A. Drachtman, Adam Lamble, Christopher J. Forlenza, Andrew Doan, Sarah C. Rutherford, Andrew M Evens, Richard F. Little, Malcolm A. Smith, Joo Y Song, Sonali M. Smith, Jonathan W. Friedberg, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 610.
https://doi.org/10.1182/blood-2023-180107
Published: 2023
Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 181.
https://doi.org/10.1182/blood-2023-180114
Published: 2023
Journal Articles

Zanubrutinib and Venetoclax As Initial Therapy for CLL/SLL with Obinutuzumab Triplet Consolidation in Patients with Minimal Residual Disease Positivity (BruVenG)

John N. Allan, Daniel Helbig, Erin Mulvey, Sarah Nazir, Sandra Stewart, Melissa L. Lapinta, Sarah C. Rutherford, Jia Ruan, John P. Leonard, Peter Martin, Richard R. Furman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3285.
https://doi.org/10.1182/blood-2023-174465
Published: 2023
Journal Articles

Outcomes of Sequential CD19-Directed Therapies in Relapsed and Refractory Large B Cell Lymphoma

David A Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Hamuza Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham Wehmeyer, Jason T. Romancik, Behzad Amoozgar, Lori A. Leslie, Loretta J. Nastoupil, Jennifer L Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami J. Maddocks, Sarah C. Rutherford, Brad S. Kahl, Michelle Okwali, Michael Buege, Venkatraman Seshan, Connie Wing-Ching Lee Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 3136.
https://doi.org/10.1182/blood-2023-182204
Published: 2023
Journal Articles

Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL

Clinical Trials & Observations
Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov, Grigorii Nos, Maria Sorokina, Vladislav Maksimov, Andrea Sboner, Michael Sigouros, Koen van Besien, Steven Horwitz, Sarah C. Rutherford, Erin Mulvey, Maria V. Revuelta, Jenny Xiang, Alicia Alonso, Ari Melnick, Olivier Elemento, Giorgio Inghirami, John P. Leonard, Leandro Cerchietti, Peter Martin
Journal: Blood
Blood (2023) 141 (18): 2194–2205.
https://doi.org/10.1182/blood.2022018254
Published: 2023
Includes: Supplemental data
Journal Articles

Phase 2 Trial of Acalabrutinib-Lenalidomide-Rituximab (ALR) with Real-Time Monitoring of MRD in Patients with Treatment-Naïve Mantle Cell Lymphoma

Jia Ruan, John P. Leonard, Gui Zhen Chen, Zhengming Chen, John N. Allan, Sarah C. Rutherford, Brittany Hobbie, Katie Greig, Amelyn Rodriguez, Wayne Tam, David A. Bond, Bijal D. Shah, Kami J. Maddocks, Bhavneet Binder, Giorgio Inghirami, Olivier Elemento, Selina Chen-Kiang, Peter Martin
Journal: Blood
Blood (2022) 140 (Supplement 1): 175–177.
https://doi.org/10.1182/blood-2022-158656
Published: 2022
Journal Articles

Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study

David Qualls, Michael J Buege, Phuong Dao, Paolo F. Caimi, Sarah C. Rutherford, Graham Wehmeyer, Jason T. Romancik, Lori A. Leslie, Mwanasha H. Merrill, Jennifer L. Crombie, Behzad Amoozgar, Brad S. Kahl, David A. Bond, Kami J. Maddocks, Michelle Okwali, Venkatraman Seshan, Gilles Salles, Connie Lee Batlevi
Journal: Blood
Blood (2022) 140 (Supplement 1): 787–789.
https://doi.org/10.1182/blood-2022-167620
Published: 2022
Journal Articles

Closing the Gap: Implementation of a Novel Interactive Virtual Tumor Board to Improve Expert Knowledge Sharing in Malignant Hematology

Jordan Ciuro, Elizabeth Henry, Nadine Housri, Rahul Banerjee, Elizabeth A Brem, Taylor Brooks, Ben A. Derman, Brian T. Hill, Craig C Hofmeister, Matthew A. Lunning, Matthew J. Matasar, Tycel J. Phillips, Sarah C. Rutherford, Saurabh Zanwar, Lauren E Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 13180–13181.
https://doi.org/10.1182/blood-2022-167959
Published: 2022
Journal Articles

Genomic and Transcriptional Characterization of Primary Mediastinal Large B Cell Lymphoma

Rebecca J Leeman-Neill, Devang Thakkar, Sarah L. Ondrejka, Eric D. Hsi, Amy Chadburn, Mateo Mejia Saldarriaga, Sarah C. Rutherford, Chad M. McCall, Tareq Aljurf, Matthew McKinney, Jean L. Koff, David L Jaye, Jonathon B. Cohen, Dina Sameh Soliman, Abner Louissaint, Jr., Choon Kiat Ong, Chee Leong Cheng, Lianne Lee, Amir Behdad, Peter H. Norgaard, Andrew G Evans, Rashmi S. Goswami, Ridas Juskevicius, Mary Ann Arildsen, Kikkeri N Naresh, Caroline J Roth, Sandeep S. Dave, Govind Bhagat
Journal: Blood
Blood (2021) 138 (Supplement 1): 2398.
https://doi.org/10.1182/blood-2021-149745
Published: 2021
Journal Articles

ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis

Kwok Him Rex Au Yeung, Veronica Russell, William Choi, Alice Wong, Lawrence Tsui, Yu Yan Carmen Lee, Jamilla Li, Harinder Gill, Ho-Wan Ip, Yok Lam Kwong, Tushar Dave, Sarah L. Ondrejka, Govind Bhagat, Amy Chadburn, Sarah C. Rutherford, Jean L. Koff, David L Jaye, Magdalena Czader, Abner Louissaint, Jr., Shaoying Li, Jie Xu, C. Cameron Yin, Choon Kiat Ong, Chee Leong Cheng, Amir Behdad, Andrew M. Evens, Peter H. Norgaard, Anne Ortved Gang, Sirpa Leppa, Marja-Liisa Karjalainen-Lindsberg, Jennifer R Chapman, Catalina Amador, Javeed Iqbal, Yuri Fedoriw, Agata M. Bogusz, Andrew G Evans, Ridas Juskevicius, Eric D. Hsi, Kikkeri N Naresh, Sandeep S. Dave, Eric Tse
Journal: Blood
Blood (2021) 138 (Supplement 1): 2403.
https://doi.org/10.1182/blood-2021-148807
Published: 2021
Journal Articles

High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II Study

Jia Ruan, Alison J. Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Riyaad Rahim, Wei Song, Nikita Kotlov, Grigorii Nos, Vladislav Maksimov, Maria Victoria Revuelta, Andrea Sboner, Michael Sigouros, Koen van Besien, Steven M. Horwitz, Sarah C. Rutherford, Erin C. Mulvey, Morton Coleman, Ari Melnick, Olivier Elemento, Giorgio Inghirami, John P. Leonard, Peter Martin, Leandro Cerchietti
Journal: Blood
Blood (2021) 138 (Supplement 1): 138.
https://doi.org/10.1182/blood-2021-145495
Published: 2021
Journal Articles

A Phase I Study of Selinexor and R-ICE in Patients with Relapsed/Refractory Aggressive B-Cell Lymphomas

Sarah C. Rutherford, MD, John N. Allan, MD, Jia Ruan, MD PhD, Richard R. Furman, MD, Kristy Richards, MD PhD, Amelyn Rodriguez, BSN, RN, OCN, Kseniya Gololobova, Arcania Garcia, Leandro Cerchietti, MD, Rossella Marullo, MDPhD, Zhengming Chen, PhD MPH, MS, Jennifer Santamala, PharmD, Tsiporah B. Shore, MD, Adrienne A. Phillips, MD MPH, Sebastian Mayer, MD, Jingmei Hsu, MD, Usama Gergis, MD, Silvia Senese, Trisha Ali-Shaw, Riyaad Rahim, Koen van Besien, MD PhD, John P. Leonard, MD, Peter Martin, FRCPC, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-134699
Published: 2020
Journal Articles

XPO1 Relieves MYC-Induced Replication Stress Limiting the Immunogenicity of DLBCL Cells

Rossella Marullo, MDPhD, Maria Victoria Revuelta, PhD, Nahuel Zamponi, PhD, Sarah C. Rutherford, MD, Peter Martin, FRCPC, MD MS, Giorgio Inghirami, MD, John P. Leonard, MD, Leandro Cerchietti, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18.
https://doi.org/10.1182/blood-2020-141464
Published: 2020
Journal Articles

SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Alex F. Herrera, MD, Hongli Li, MS, Sharon M. Castellino, MD MSc, Sarah C. Rutherford, MD, Kelly Davison, MD, Andrew G Evans, DO, MSc, Angela Punnett, MD, Louis S. Constine, MD, David C. Hodgson, MD MPH, FRCPC, Susan K Parsons, MD MRP, Anca Prica, MD, Lale Kostakoglu, Prof, MD PhD, Margaret A. Shipp, MD, Cara Laubach, Michael L. Leblanc, PhD, Michael Crump, MD, Brad S. Kahl, MD, John P. Leonard, MD, Kara M. Kelly, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MSSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136422
Published: 2020